Thomas W. Hofmann is Director at WEST PHARMACEUTICAL SERVICES INC (WST). They have made 6 open-market trades across 3 companies since 2011, most recently 2025-05-06.
CIK 0001174597
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $307K since 2011, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WST | SELL | 2024-05-10 | 2024-08-21 | $365.92 | $452K | -0.9% | +0.4% | -0.9% |
| WST | SELL | 2023-05-01 | 2023-05-02 | $365.58 | $886K | -3.6% | -8.6% | -1.5% |
| WST | SELL | 2016-05-25 | 2016-05-25 | $73.57 | $363K | +3.4% | -1.2% | +10.3% |
| WST | SELL | 2016-02-29 | 2016-03-01 | $62.70 | $381K | +2.4% | +9.0% | +18.0% |
| CPPL | BUY | 2015-02-11 | 2015-02-13 | $23.00 | $115K | -17.6% | +3.3% | +3.3% |
| PVR | BUY | 2011-11-15 | 2011-11-16 | $23.96 | $192K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.